Pfizer CEO has met with the new administration and believes Trump and RFK Jr. are going to be net positives for the health ...

In an interview on CNBC’s Mad Money, Dr. Albert Bourla said Pfizer (PFE) is focusing on business development to create shareholder value. “We ...

The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market for deals to fill its drug pipeline and power sales growth into the 2030s, ...

Pfizer Inc. got a reprieve — at least for now — in its battle with activist investor Starboard Value LP, according to people ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

I guess we'll see," Pfizer CEO Albert Bourla said during a presentation ... available this year to move them forward," Ubl said in an interview with CNBC. He also pointed to a previous Trump ...